NL Industries remains a strong long-term income play, despite recent share price decline and rangebound technicals. NL's real trailing dividend yield is an impressive 10.4%, boosted by special ...

New to N.I.N.A.? In this beginner-friendly tutorial, I walk you through setting up your first sequence from scratch using the powerful N.I.N.A. sequencer. Perfect for automating your imaging session ...

Kronos Worldwide, Inc. KRO reported a second-quarter 2025 loss of 8 cents per share. This compares unfavorably with earnings of 17 cents in the year-ago quarter. The figure missed the Zacks Consensus ...

Investing.com -- S&P Global Ratings downgraded Concord, Ontario-based Kronos Acquisition Holdings Inc. to ’CCC+’ from ’B-’ due to tightening liquidity and ongoing operational challenges. The downgrade ...

Instead of just including a library of pre-recorded samples captured from percussion instruments like marimbas and xylophones, Korg Berlin’s Phase8 features eight “replaceable and tunable metal ...

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and ...

Kronos Worldwide, Inc. KRO reported fourth-quarter 2024 loss of 12 cents per share, wider than a loss of 5 cents per share a year ago. The Zacks Consensus Estimate was earnings of 11 cents per share.

Kronos Worldwide reports fourth quarter 2024 net loss of $13.2 million; full year 2024 net income rises to $86.2 million. Kronos Worldwide, Inc. announced a net loss of $13.2 million, or $.12 per ...

Big names returned to the annual National Association of Music Merchants Show in 2025, bringing with them a plethora of musical products from the old school to the futuristic. Companies like Boss, ...

The clock is ticking for Kronos Bio after the biotech discontinued its last remaining clinical-stage asset over neurological adverse events. The San Mateo, California-based biotech said it had made ...